Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS
· Delayed Price · Currency is USD
0.400
0.00 (0.00%)
Mar 9, 2026, 3:37 PM EST
Elite Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | 43.41 | -4.31 | 20.11 | 3.56 | 8.9 | 5.09 | Upgrade
|
| Depreciation & Amortization | 2.05 | 2.12 | 1.52 | 1.33 | 1.42 | 1.51 | Upgrade
|
| Other Amortization | 0.01 | 0.01 | - | 0.01 | 0.01 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.12 | - | - | - | -0.05 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.6 | 1.6 | - | 0.29 | - | - | Upgrade
|
| Stock-Based Compensation | 0.2 | 0.23 | 6.75 | 0.58 | 0.78 | 0.94 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.05 | 0.15 | 0.24 | - | - | - | Upgrade
|
| Other Operating Activities | 4.77 | 22.7 | -19.96 | -0.43 | -3.6 | -2.25 | Upgrade
|
| Change in Accounts Receivable | -31.13 | -9.9 | -16.6 | -0.04 | 0.44 | 0.61 | Upgrade
|
| Change in Inventory | -4.94 | -3.31 | -3.38 | -2.81 | -1.73 | -0.87 | Upgrade
|
| Change in Accounts Payable | 0.68 | 0.24 | 0.02 | 1.34 | 0.31 | -1.77 | Upgrade
|
| Change in Unearned Revenue | -0.01 | -0.01 | -0.01 | - | -0.01 | -0.18 | Upgrade
|
| Change in Other Net Operating Assets | 0.82 | -2.18 | 8.07 | -0.5 | -0.02 | 0.15 | Upgrade
|
| Operating Cash Flow | 18.52 | 7.46 | -3.24 | 3.34 | 6.51 | 3.19 | Upgrade
|
| Operating Cash Flow Growth | 228.53% | - | - | -48.70% | 103.78% | - | Upgrade
|
| Capital Expenditures | -1.28 | -1.63 | -0.81 | -5.74 | -0.5 | -0.33 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.13 | - | - | - | 0.07 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.9 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -1.28 | -2.4 | -0.81 | -5.74 | -0.5 | -0.26 | Upgrade
|
| Short-Term Debt Issued | - | - | 4 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 14.44 | - | 1.01 | Upgrade
|
| Total Debt Issued | - | - | 4 | 14.44 | - | 1.01 | Upgrade
|
| Long-Term Debt Repaid | - | -0.85 | -0.66 | -12.74 | -0.67 | -1.93 | Upgrade
|
| Total Debt Repaid | -4.68 | -0.85 | -0.66 | -12.74 | -0.67 | -1.93 | Upgrade
|
| Net Debt Issued (Repaid) | -4.68 | -0.85 | 3.34 | 1.7 | -0.67 | -0.91 | Upgrade
|
| Issuance of Common Stock | 0.26 | 0.02 | - | - | - | 0.04 | Upgrade
|
| Financing Cash Flow | -4.42 | -0.83 | 3.34 | 1.7 | -0.67 | -0.87 | Upgrade
|
| Net Cash Flow | 12.82 | 4.23 | -0.71 | -0.7 | 5.34 | 2.06 | Upgrade
|
| Free Cash Flow | 17.24 | 5.83 | -4.04 | -2.4 | 6.01 | 2.86 | Upgrade
|
| Free Cash Flow Growth | 295.14% | - | - | - | 109.85% | - | Upgrade
|
| Free Cash Flow Margin | 12.30% | 6.94% | -7.14% | -7.02% | 18.63% | 11.28% | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.01 | -0.00 | -0.00 | 0.01 | 0.00 | Upgrade
|
| Cash Interest Paid | 0.33 | 0.67 | 0.12 | 1.1 | 0.18 | 0.18 | Upgrade
|
| Cash Income Tax Paid | 0.9 | 0.61 | 0.29 | 0.42 | - | - | Upgrade
|
| Levered Free Cash Flow | -0.47 | -2.18 | -4.87 | -4.55 | 3.6 | 1.11 | Upgrade
|
| Unlevered Free Cash Flow | -0.17 | -1.71 | -4.5 | -3.87 | 3.71 | 1.26 | Upgrade
|
| Change in Working Capital | -34.58 | -15.17 | -11.89 | -2.01 | -1.01 | -2.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.